| EANO guidelines for the diagnosis and treatment of ependymal tumors R Rudà, G Reifenberger, D Frappaz, SM Pfister, A Laprie, T Santarius, ... Neuro-oncology 20 (4), 445-456, 2018 | 253 | 2018 |
| Magnetic resonance imaging for secondary assessment of breast density in a high-risk cohort C Klifa, J Carballido-Gamio, L Wilmes, A Laprie, J Shepherd, J Gibbs, ... Magnetic resonance imaging 28 (1), 8-15, 2010 | 142 | 2010 |
| Quantification of breast tissue index from MR data using fuzzy clustering C Klifa, J Carballido-Gamio, L Wilmes, A Laprie, C Lobo, E Demicco, ... The 26th Annual International Conference of the IEEE Engineering in Medicine …, 2004 | 136 | 2004 |
| Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy A Laprie, A Pirzkall, DA Haas-Kogan, S Cha, A Banerjee, TP Le, Y Lu, ... International Journal of Radiation Oncology* Biology* Physics 62 (1), 20-31, 2005 | 134 | 2005 |
| Cardiac diseases following childhood cancer treatment: cohort study N Haddy, S Diallo, C El-Fayech, B Schwartz, F Pein, M Hawkins, C Veres, ... Circulation 133 (1), 31-38, 2016 | 121 | 2016 |
| Proton magnetic resonance spectroscopic imaging in newly diagnosed glioblastoma: predictive value for the site of postradiotherapy relapse in a prospective longitudinal study A Laprie, I Catalaa, E Cassol, TR McKnight, D Berchery, D Marre, ... International Journal of Radiation Oncology* Biology* Physics 70 (3), 773-781, 2008 | 120 | 2008 |
| Integration method of 3D MR spectroscopy into treatment planning system for glioblastoma IMRT dose painting with integrated simultaneous boost S Ken, L Vieillevigne, X Franceries, L Simon, C Supper, JA Lotterie, ... Radiation oncology 8, 1-9, 2013 | 94 | 2013 |
| Online quality control, hyperfractionated radiotherapy alone and reduced boost volume for standard risk medulloblastoma: long-term results of MSFOP 98 C Carrie, J Grill, D Figarella-Branger, V Bernier, L Padovani, JL Habrand, ... Journal of clinical oncology 27 (11), 1879-1883, 2009 | 93 | 2009 |
| Management of vertebral radiotherapy dose in paediatric patients with cancer: consensus recommendations from the SIOPE radiotherapy working group BA Hoeben, C Carrie, B Timmermann, HC Mandeville, L Gandola, ... The Lancet Oncology 20 (3), e155-e166, 2019 | 71 | 2019 |
| Paediatric brain tumours: a review of radiotherapy, state of the art and challenges for the future regarding protontherapy and carbontherapy A Laprie, Y Hu, C Alapetite, C Carrie, JL Habrand, S Bolle, PY Bondiau, ... Cancer/Radiothérapie 19 (8), 775-789, 2015 | 70 | 2015 |
| High‐dose chemotherapy followed by locoregional irradiation improves the outcome of patients with international neuroblastoma staging system Stage II and III neuroblastoma with … A Laprie, J Michon, O Hartmann, C Munzer, MD Leclair, C Coze, ... Cancer 101 (5), 1081-1089, 2004 | 61 | 2004 |
| Comparison of static and dynamic 18F-FDG PET/CT for quantification of pulmonary inflammation in acute lung injury A Braune, F Hofheinz, T Bluth, T Kiss, J Wittenstein, M Scharffenberg, ... Journal of Nuclear Medicine 60 (11), 1629-1634, 2019 | 58* | 2019 |
| Phase I trial of tipifarnib (R115777) concurrent with radiotherapy in patients with glioblastoma multiforme ECJ Moyal, A Laprie, M Delannes, M Poublanc, I Catalaa, F Dalenc, ... International Journal of Radiation Oncology* Biology* Physics 68 (5), 1396-1401, 2007 | 58 | 2007 |
| Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with … A Laprie, S Ken, T Filleron, V Lubrano, L Vieillevigne, F Tensaouti, ... BMC cancer 19, 1-10, 2019 | 55 | 2019 |
| Evaluation of the lactate-to-N-acetyl-aspartate ratio defined with magnetic resonance spectroscopic imaging before radiation therapy as a new predictive marker of the site of … A Deviers, S Ken, T Filleron, B Rowland, A Laruelo, I Catalaa, V Lubrano, ... International Journal of Radiation Oncology* Biology* Physics 90 (2), 385-393, 2014 | 55 | 2014 |
| αvβ3 Integrin and Fibroblast growth factor receptor 1 (FGFR1): Prognostic factors in a phase I–II clinical trial associating continuous administration of Tipifarnib with … A Ducassou, E Uro-Coste, P Verrelle, T Filleron, A Benouaich-Amiel, ... European Journal of Cancer 49 (9), 2161-2169, 2013 | 55 | 2013 |
| Thyroid radiation dose and other risk factors of thyroid carcinoma following childhood cancer F de Vathaire, N Haddy, RS Allodji, M Hawkins, C Guibout, C El-Fayech, ... The Journal of Clinical Endocrinology & Metabolism 100 (11), 4282-4290, 2015 | 49 | 2015 |
| The role of radiation therapy in pediatric mucoepidermoid carcinomas of the salivary glands J Thariat, PO Vedrine, S Temam, AM Ali, D Orbach, G Odin, M Makeieff, ... The Journal of pediatrics 162 (4), 839-843, 2013 | 47 | 2013 |
| Long-term side effects of radiotherapy for pediatric localized neuroblastoma A Ducassou, M Gambart, CM MScRes, MD Laetitia Padovani, C Carrie, ... Strahlentherapie und Onkologie 191 (7), 604, 2015 | 44 | 2015 |
| Risk of second bone sarcoma following childhood cancer: role of radiation therapy treatment B Schwartz, MA Benadjaoud, E Cléro, N Haddy, C El-Fayech, C Guibout, ... Radiation and environmental biophysics 53, 381-390, 2014 | 44 | 2014 |
fatima tensaoutiInserm Researcher, Toulouse Neuroimaging center, ToNIC (INSERM-UT3), TMBI (Univ Toulouse)在 chu-toulouse.fr 的电子邮件经过验证
